Management of gynaecologic plasmacytoma: A review article.
Feldman AM et al. J Obstet Gynaecol. 2016 Oct 19:1-6. [Epub ahead of print].
Current treatments for renal failure due to multiple myeloma.
Gavriatopoulou M et al. Expert Opin Pharmacother. 2016 Nov;17(16):2165-2177. Epub 2016 Sep 27.
Comparative Confocal and Histopathological Study of Corneal Changes in Multiple Myeloma.
Micali A et al. Cornea. 2016 Oct 5. [Epub ahead of print].
Photoclinic Diagnosis: Puffy Hands as the Initial Manifestation of Multiple Myeloma.
Shariati-Sarabi Z et al. Arch Iran Med. 2016 Oct;19(10):741-742.
Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study.
Bhatti S et al. Int J Cardiovasc Imaging. 2016 Oct 14. [Epub ahead of print].
Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.
Gaiani A et al. Neurol Sci. 2016 Oct 7. [Epub ahead of print].
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.
Teh BW et al. Eur J Haematol. 2016 Sep 26. doi: 10.1111/ejh.12813. [Epub ahead of print].
Mandibular destructive radiolucent lesion: The first sign of multiple myeloma.
Fregnani ER et al. J Clin Exp Dent. 2016 Oct 1;8(4):e465-e468. eCollection 2016.
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
Marchica V et al. Int J Hematol. 2016 Oct 3. [Epub ahead of print].
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
Mohan M et al. Transpl Infect Dis. 2016 Oct 1. doi: 10.1111/tid.12619. [Epub ahead of print].